Latest news

Останні новини

thumbnail_Group 642.png

Group 642.png

At the beginning of the year, Alkaloid Ukraine held its Winter Kick-Off Meeting in Truskavets, a renowned spa city in the Carpathian region of Ukraine. Known for its healing waters and calm atmosphere, Truskavets created the right environment for strategic reflection, professional development, and meaningful team interaction. Stepping away from everyday operational routines allowed the team to focus on long-term goals, shared values, and the challenges ahead.

Alkaloid UA Winter Kick-Off Meeting 2026:  Results, Learning, and Shared Responsibility for the Future

Alkaloid UA Winter Kick-Off Meeting 2026

The primary purpose of the Microbiological Quality Control Laboratory – Alkaloid AD’s latest €3.1 million investment – is to deliver the highest standards of microbiological quality control across raw materials, primary packaging, intermediates, and finished products.

ALKALOID’S NEW MICROBIOLOGICAL QUALITY CONTROL LABORATORY COMMISSIONED DURING OFFICIAL GOVERNMENT DELEGATION VISIT

As the holder of the first international value-added medicine patent – liquid&nbsp;Omeprazole, ready to use – Alkaloid sponsored the First International Conference on Modern Approaches to GERD Treatment in Pediatric Patients, held in Zagreb, Croatia.

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE SOLUTIONS IN PEDIATRIC GERD TREATMENT HELD IN ZAGREB

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE

ALKALOID reached consolidated sales of EUR 84.5 million, consolidated export of EUR 57.4 million and invested EUR 4.2 million in the January – March 2025 period.

Visit your local Alkaloid website

Serbia

Romania

Croatia

Ukraine

Bulgaria

Bosnia and Herzegovina

Latest news

Alkaloid UA Winter Kick-Off Meeting 2026

ALKALOID’S NEW MICROBIOLOGICAL QUALITY CONTROL LABORATORY COMMISSIONED DURING OFFICIAL GOVERNMENT DELEGATION VISIT

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE

ALKALOID – operating results for the January – March 2025 period